相关实验视频
Updated: Jun 28, 2025

05:53
An Effective Mouse Model of Unilateral Renal Ischemia-Reperfusion Injury
Published on: July 15, 2021
6.7K
在感染性内心炎的心脏手术后,德克斯梅德托米丁对功能的影响:一项随机对照试验的临时分析
Sung Yeon Ham1, Jae-Kwang Shim1, Sak Lee2
1Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
Asian journal of surgery
|April 24, 2024
概括
在感染性内心炎 (IE) 心脏手术后,德克斯梅德托米丁显著降低了急性损伤 (AKI). 这种治疗可以使AKI发病率降低29%,而不会引起血液动力学副作用.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 麻醉学 麻醉学
背景情况:
- 由于感染性内心炎 (IE) 而接受心脏手术的患者面临着术后急性损伤 (AKI) 的高风险.
- 系统性炎症的增加是这些患者AKI的关键因素.
研究的目的:
- 为了研究德克斯梅德托米丁对手术后AKI的影响,在接受IE心脏手术的患者中.
- 评估德克斯梅托米丁是否可以减轻高风险手术患者群体中AKI的风险.
主要方法:
- 一项随机试验,涉及63名因IE接受心脏手术的患者.
- 患者在麻醉诱导后24小时内接受静脉注射德克斯梅德托米丁 (0.4μg kg-1h-1) 或正常盐水.
- 结果包括AKI发生在七天内,炎症标志物 (干白素-6) 和 катехо胺水平 (上腺素,上腺素).
主要成果:
- 该试验因临时分析显示,德克斯梅托米丁组AKI发病率显著降低 (9.4%与32.3%相比) 而提前结束.
- 与对照组相比,德克斯梅德托米丁显著降低了手术后血清上腺素水平.
- 在上腺素,白蛋白-6水平或血液动力学参数 (平均动脉压,心率) 中没有发现显著差异.
结论:
- 持续24小时的德克斯梅德托米丁输液显著降低了手术后AKI发病率,在接受IE心脏手术的患者中,这一比例为29%.
- 观察到的益处在没有不良的血液动力学影响的情况下实现.
- 德克斯梅德托米丁的使用减轻了血清上腺素水平的术后激增.
相关概念视频
Heart Failure Drugs: Inotropic Agents
574
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
574
Skeletal Muscle Relaxants: Adverse Effects
361
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
361
Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88

